Categories: News

Outset Medical to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2021 after the close of trading on Wednesday, November 3, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Wednesday, November 3, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 7975557. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Lynn Lewis or Brian Johnston

Gilmartin Group

investors@outsetmedical.com

Staff

Recent Posts

TEDCO’s Maryland Innovation Initiative Announces FY2025 Technology Assessment Awards

Over $1 million awarded to 7 university projects  COLUMBIA, Md., April 24, 2025 /PRNewswire/ -- TEDCO,…

32 minutes ago

RS and Siemens are paving the way to Industry 5.0 with I/O

RS offers Siemens IP6X distributed I/O systems engineered to satisfy organizations' ever-increasing demand for actionable…

32 minutes ago

INAUGURAL FUTURE WAY FORWARD CONFERENCE INVITES AMERICA TO COME TOGETHER — FOR REAL AND FOR GOOD

Physician turned founder creates new opportunity for collaboration, growth, and positive social changeNASHVILLE, Tenn., April…

32 minutes ago

KONZA National Network Joins Missouri eLTSS Project Phase 2 to Advance Person-Centered Care for Individuals with IDD

TOPEKA, Kan., April 24, 2025 /PRNewswire/ -- KONZA National Network is proud to announce its partnership…

32 minutes ago

ApolloMD Partners with Cleo Health to Transform Emergency Medicine Documentation Through AI Innovation

ATLANTA, April 24, 2025 /PRNewswire/ -- ApolloMD, one of the nation's leading physician services organizations, today…

32 minutes ago

BISSELL Takes on Shedding Season with its Most Powerful Stick Vacuum Yet

PowerClean® FurFinder™ and PowerClean® FurGuard™ cordless stick vacuums find and powerfully capture pet hair and…

32 minutes ago